Factors associated with stockout of Nevirapine syrup in Oshana Region, Namibia.

Nevirapine syrup Stock out supply chain

Journal

Journal of public health in Africa
ISSN: 2038-9922
Titre abrégé: J Public Health Afr
Pays: Italy
ID NLM: 101586943

Informations de publication

Date de publication:
31 Dec 2019
Historique:
received: 28 01 2019
accepted: 17 10 2019
entrez: 8 4 2020
pubmed: 8 4 2020
medline: 8 4 2020
Statut: epublish

Résumé

Infants who are born with HIV/AIDS is still a public health concern in developing countries, especially in Sub Saharan Africa. In Namibia, it is estimated that the prevalence rate of HIV pregnant women is around 17.2%, makes it to be among the countries with the highest prevalence rates among HIV women in sub-Saharan Africa (SSA). Some improvement regarding Prevention of Mother to Child Transmission has been made, however, frequent stock out of Nevirapine syrup continues to slow down, government efforts to foster the emergence of an HIV-free generation of Namibians. Given the nature of current conditions, justification exists for a study to determine the factors associated with stock out of Nevirapine (NVP) syrup.Mixed method was employed. In which descriptive approach was employed to acquire data from a period of five years retrospectively (2012-2016) and informants from different levels of supply chain in Oshana region. Initial, order receiving is not a predictor of NVP syrup. Lack of pharmaceutical knowledge is the biggest challenge which leads to sporadic stock out of NVP syrup. Pharmaceutical knowledge of ordering NVP syrup is needed to prevent stock out of NVP syrup. It is a recommendation of this study that training is needed for staffs who are involved in ordering of pharmaceutical items.

Identifiants

pubmed: 32257074
doi: 10.4081/jphia.2019.1035
pmc: PMC7118430
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1035

Informations de copyright

©Copyright: the Author(s), 2019.

Déclaration de conflit d'intérêts

Conflict of interest: The authors declare no potential conflict of interest.

Références

Iran J Pharm Res. 2012 Spring;11(2):565-72
pubmed: 24250480
Kolner Z Soz Sozpsychol. 2017;69(Suppl 2):107-131
pubmed: 28989188
J Pharm Policy Pract. 2014 Apr 22;7:3
pubmed: 25848543
Health Policy Plan. 2017 Oct 1;32(8):1127-1134
pubmed: 28541542
J Pharm Policy Pract. 2016 Mar 31;9:11
pubmed: 27042314
PLoS One. 2019 Mar 12;14(3):e0212405
pubmed: 30861000
Glob Health Sci Pract. 2016 Mar 25;4(1):165-77
pubmed: 27016552

Auteurs

Emmanuel Magesa (E)

School of Public Health, University of Namibia, Namibia.

Kabwebwe Honore Mitonga (KH)

School of Public Health, University of Namibia, Namibia.

Penehafo Angula (P)

School of Public Health, University of Namibia, Namibia.

Classifications MeSH